SCHEMBL7701907

SCHEMBL7701907

CC(C)(O)C#CCC(C)(C)CCCC=O

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
HIF1A Q16665 1/20 0.31
FFAR1 O14842 1/20 0.31
CPT2 P23786 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7704389 0.77
SCHEMBL7704780 0.76 CYP4F2 (0.31)
SCHEMBL7704790 0.71 ALDH1A1 (0.38) TSHRHIF1AFFAR1CPT2TDP1
SCHEMBL27785813 0.69 TSHR (0.46) TSHRHIF1AFFAR1CPT2TDP1
SCHEMBL27509626 0.69
SCHEMBL16600187 0.69
SCHEMBL1785190 0.68 TSHR (0.48) TSHRHIF1AFFAR1CPT2TDP1
Glutaral SCHEMBL29229225 0.66 HIF1A (0.62) TSHRHIF1ATDP1
SCHEMBL1783206 0.66 TSHR (0.59) TSHRHIF1AFFAR1CPT2TDP1
SCHEMBL1784663 0.66 TSHR (0.52) TSHRHIF1AFFAR1CPT2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056716-B1 CYCLOHEXANEDIOLE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2002-12-11 EP disclosed
US-6184422-B1 TREATMENT AND PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES; REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE; ANTITUMOR, -CARCINOGENIC AGENTS; PSORIASIS; DISORDERS OF NEOPLASTIC DISEASES; KERATINIZATION/KERATOSIS; ACNE; SEBORRHEA HOFFMAN-LA ROCHE INC. 2001-02-06 US disclosed
EP-1056716-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-06 EP disclosed
WO-1999043646-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed